Evidence map›Paper›PMID 25565807›Full record

ReviewInternational journal of nanomedicine2015

Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity.

Yeon Kyung Lee, Eun-Ju Choi, Thomas J Webster, Sang-Hyun Kim, Dongwoo Khang

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yeon Kyung LeeDepartment of Molecular Medicine, School of Medicine, Gachon University, Incheon, South Korea.
Eun-Ju ChoiDivision of Sport Science, College of Science and Technology, Konkuk University, Chungju, South Korea.
Thomas J WebsterDepartment of Chemical Engineering and Program in Bioengineering, Northeastern University, Boston, MA, USA.
Sang-Hyun KimDepartment of Pharmacology, School of Medicine, Kyungpook National University, Daegu, South Korea.
Dongwoo KhangDepartment of Molecular Medicine, School of Medicine, Gachon University, Incheon, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the cytotoxicity of nanoparticles (NPs) is greatly influenced by their interactions with blood proteins, toxic effects resulting from blood interactions are often ignored in the development and use of nanostructured biomaterials for in vivo applications. Protein coronas created during the initial reaction with NPs can determine the subsequent immunological cascade, and protein coronas formed on NPs can either stimulate or mitigate the immune response. Along these lines, the understanding of NP-protein corona formation in terms of physiochemical surface properties of the NPs and NP interactions with the immune system components in blood is an essential step for evaluating NP toxicity for in vivo therapeutics. This article reviews the most recent developments in NP-based protein coronas through the modification of NP surface properties and discusses the associated immune responses.

Indexed as

Blood ProteinsCell Line, TumorCell SurvivalDrug Delivery SystemsHumansHuman Umbilical Vein Endothelial CellsImmunity, ActiveNanoparticlesProtein CoronaSurface PropertiesBlood ProteinsProtein Coronablood responsecytotoxicityimmunotoxicitynanostructured biomaterialsprotein corona

Identifiers

PMID25565807
PMCPMC4275058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.